Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
Top Cited Papers
- 10 June 2008
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 70 (24) , 2277-2283
- https://doi.org/10.1212/01.wnl.0000304039.11891.29
Abstract
Background: Mutations in GBA and LRRK2 genes have been implicated in Parkinson disease (PD), particularly in Ashkenazi Jews. Methods: An Israeli Ashkenazi cohort of 420 patients with PD, 333 elderly controls, and 3,805 young controls was screened for eight GBA mutations, which are associated with mild (N370S, R496H) and severe (84GG, IVS2 + 1, V394L, D409H, L444P, RecTL) Gaucher disease. Patients with PD and elderly controls were also genotyped for LRRK2 G2019S. Results: GBA carrier frequency was 17.9% in patients with PD compared to 4.2% in elderly and 6.35% in young controls. The proportion of severe mutation carriers among PD patient GBA carriers was 29% compared to 7% among young controls. Severe and mild GBA mutations increased the risk of developing PD by 13.6- and 2.2-fold, and affected the average age at PD onset (AAO), 55.7 and 57.9 years, compared to 60.7 years in patients without known GBA or LRRK2 mutations. Conclusions: These data demonstrate genotype-phenotype correlations between different GBA mutations and Parkinson disease (PD) risk and AAO in Ashkenazi Jews. Additionally, an earlier AAO was observed in LRRK2 G2019S carrier PD patients. Finally, these data demonstrate that a surprisingly high frequency, more than one third of our patient population, carried a mutation in GBA or LRRK2.Keywords
This publication has 31 references indexed in Scilit:
- Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among TaiwaneseJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson diseaseMolecular Genetics and Metabolism, 2007
- Genetics of Parkinson disease: paradigm shifts and future prospectsNature Reviews Genetics, 2006
- Gaucher disease and parkinsonismMolecular Genetics and Metabolism, 2005
- Molecular Pathways of Neurodegeneration in Parkinson's DiseaseScience, 2003
- Parkinson's DiseaseNeuron, 2003
- Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?Molecular Genetics and Metabolism, 2003
- Gaucher Disease and Parkinsonism: A Phenotypic and Genotypic CharacterizationMolecular Genetics and Metabolism, 2001
- Occurrence of Parkinson's syndrome in type 1 Gaucher diseaseQJM: An International Journal of Medicine, 1996
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992